Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

News Daily News

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

December 22, 2020

DOACs May Up Post-TAVR Survival in A-fib: OCEAN-TAVI

News Daily News

DOACs May Up Post-TAVR Survival in A-fib: OCEAN-TAVI

October 29, 2020

GARFIELD-AF: Wrong DOAC Dose Can Be Lethal in A-fib

News Daily News

GARFIELD-AF: Wrong DOAC Dose Can Be Lethal in A-fib

September 16, 2020

FDA Approves Next-Generation Watchman FLX Device for LAA Occlusion

News Daily News

FDA Approves Next-Generation Watchman FLX Device for LAA Occlusion

July 22, 2020

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

News Daily News

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

June 25, 2020

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

News Daily News

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

Michael O'Riordan

June 08, 2020

More Evidence of Lower Fracture Risk With DOACs Versus Warfarin

News Daily News

More Evidence of Lower Fracture Risk With DOACs Versus Warfarin

May 19, 2020

‘Silent’ Brain Infarcts Common, Tied to Cognitive Decline in A-fib

News Daily News HRS 2020

‘Silent’ Brain Infarcts Common, Tied to Cognitive Decline in A-fib

May 14, 2020

More Support for DOAC-Based Double Therapy After PCI for A-fib Patients

News Daily News

More Support for DOAC-Based Double Therapy After PCI for A-fib Patients

March 16, 2020

New ARISTOTLE Data ‘Reassuring’ on Lower Apixaban Dose

News Daily News

New ARISTOTLE Data ‘Reassuring’ on Lower Apixaban Dose

March 12, 2020

Choosing a DOAC? Apixaban May Have an Edge Over Rivaroxaban

News Daily News

Choosing a DOAC? Apixaban May Have an Edge Over Rivaroxaban

March 09, 2020

No Stroke Reduction but Increased Bleeding With OAC in Dialysis Patients

News Daily News

No Stroke Reduction but Increased Bleeding With OAC in Dialysis Patients

January 21, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.